Back to search

Article

Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023

2026-03-10

Abstract excerpt

<h4>Background: </h4> It is increasingly suggested that clinical guidelines and practices be updated to permanently expand relaxation around access to opioid agonist treatment (OAT) take-home doses after COVID-19. Despite a risk of OAT drug diversion, flexibility in take-home doses is valued by patients and associated with improved quality of life and retention. However, few studies have examined the effects of ch...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
49eb31f0-f77e-5491-bac7-ecb087f2e65e
DOI
10.12688/hrbopenres.14044.3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023DOI 10.12688/hrbopenres.14044.3
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiencesSemantic proximity
Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPPSemantic proximity
“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatmentSemantic proximity
What constitutes safe and effective dose titration of methadone and buprenorphine/naloxone? protocol for a population-based target trial emulationSemantic proximity
Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022 - a repeated cross-sectional studySemantic proximity
The effects of a provincial opioid prescribing standard on opioid prescribing for pain: interrupted series analysisSemantic proximity
Trends in medication use after the onset of the COVID-19 pandemic in the Republic of Ireland: an interrupted time series studySemantic proximity
Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online SurveySemantic proximity
Influence of palliative care on medication: results of a retrospective analysis of 10,464 outpatients in GermanySemantic proximity
Implementing Three-Day Methadone in a Low-Threshold Bridge Clinic: Impact of OTP Referral Pathways on Treatment RetentionSemantic proximity
Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countriesSemantic proximity
Select a neighboring publication to make it the new centre.